A 21st century evil: immunopathology and new therapies of COVID-19
TF Silva, F Tomiotto-Pellissier, RA Sanfelice… - Frontiers in …, 2020 - frontiersin.org
Coronavirus Disease 2019 (COVID-19) has been classified as a global threat, affecting
millions of people and killing thousands. It is caused by the SARS-CoV-2 virus, which …
millions of people and killing thousands. It is caused by the SARS-CoV-2 virus, which …
A hitchhiker's guide through the COVID-19 galaxy
S Felsenstein, AO Reiff - Clinical Immunology, 2021 - Elsevier
Numerous reviews have summarized the epidemiology, pathophysiology and the various
therapeutic aspects of Coronavirus disease 2019 (COVID-19), but a practical guide on “how …
therapeutic aspects of Coronavirus disease 2019 (COVID-19), but a practical guide on “how …
COVID-19: immunopathogenesis and Immunotherapeutics
L Yang, S Liu, J Liu, Z Zhang, X Wan… - Signal transduction and …, 2020 - nature.com
The recent novel coronavirus disease (COVID-19) outbreak, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected …
respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected …
[HTML][HTML] Recent insight into SARS-CoV2 immunopathology and rationale for potential treatment and preventive strategies in COVID-19
As the outbreak of the new coronavirus (SARS-CoV-2) infection is spreading globally, great
effort is being made to understand the disease pathogenesis and host factors that …
effort is being made to understand the disease pathogenesis and host factors that …
Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
LM Khosroshahi, M Rokni, T Mokhtari… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …
Pathogenesis guided therapeutic management of COVID-19: an immunological perspective
Lack of standardized therapeutic approaches is arguably the significant contributor to the
high burden of mortality observed in the ongoing pandemic of the Coronavirus disease …
high burden of mortality observed in the ongoing pandemic of the Coronavirus disease …
COVID-19: immunology, immunopathogenesis and potential therapies
Abstract The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and
affected millions of people around the globe. As of January 2021, 100 million confirmed …
affected millions of people around the globe. As of January 2021, 100 million confirmed …
COVID-19: immunopathology and its implications for therapy
X Cao - Nature reviews immunology, 2020 - nature.com
Severe coronavirus disease 2019 (COVID-19) is characterized by pneumonia, lymphopenia,
exhausted lymphocytes and a cytokine storm. Significant antibody production is observed; …
exhausted lymphocytes and a cytokine storm. Significant antibody production is observed; …
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
P Goodarzi, F Mahdavi, R Mirzaei, H Hasanvand… - International …, 2020 - Elsevier
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …